iHumanvsLowe's Companies

IH and LOW stock compared: price, dividend, valuation and results, from SEC filings.

iHuman (IH) has a market value of $40M and Lowe's Companies (LOW) $124B. Over the last year, with dividends, IH moved -71.2% and LOW -1.2%. Dividend yield: IH none, LOW 2.22%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    IH$40M

    LOW$124B

    LOW is 3,071 times IH

  • Revenue, 12 months

    IH$115M

    LOW$90.4B

    LOW is 784 times IH

  • Net income, 12 months

    IH$14M

    LOW$6.6B

    LOW is 487 times IH

  • Operating margin

    IH8.3%

    LOW11.4%

    3.1 points apart

  • ROIC

    IH5.3%

    LOW27.6%

    22.3 points apart

  • P/E

    IH–

    LOW18.7

  • Dividend yield

    IH0.0%

    LOW2.2%

    2.2 points apart

  • 5-year return

    IH-81.7%

    LOW-2.2%

    79.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

IH-81.7%

LOW-2.2%

5010020222023202420252026
Returns by period
PeriodIHWith dividendsLOWWith dividends
1 year since November 19, 2025-71.2%Price -72.8%-1.2%Price -3.3%
3 years since November 20, 2023-63.6%-28.6% a yearPrice -69.1%+14.8%+4.7% a yearPrice +8.0%
5 years since November 19, 2021-81.7%-28.8% a yearPrice -84.5%-2.2%-0.5% a yearPrice -11.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

IHiHumanLOWLowe's Companies

Valuation

IHLOW
Valuation
Price$0.78$220.84
Market value$40M$124B
Enterprise value (EV)–$158B
P/E–18.7
P/E, 5-year median7.521.2
P/B0.3–
EV/EBIT–15.3
Free cash flow yield16.5%5.7%

Results and growth

IHLOW
Results and growth
Revenue, 12 months$115M$90.4B
Net income, 12 months$14M$6.6B
Free cash flow, 12 months$6.6M$7.0B
Earnings per share, 12 months$0.26$11.83
Revenue growth, year on year-12.5%3.1%
Revenue growth a year, past+8.7%over 5 years-0.8%over 5 years
EPS growth a year, past–+8.9%over 5 years

Margins and returns on capital

IHLOW
Margins and returns on capital
Gross margin67.9%33.1%
Operating margin8.3%11.4%
Net margin11.8%7.3%
ROIC5.3%27.6%
ROE9.6%–

Balance sheet

IHLOW
Balance sheet
Cash$165M$3.4B
Total debt$1.6M$42.0B
Net debt / EBITDA-15.52.7
Interest cover––

Dividends and buybacks

IHLOW
Dividends and buybacks
Dividend yield–2.2%
Dividend per share, 12 months–$4.90
Dividend growth a year, past–+15.6%over 5 years
Buyback yield6.1%0.2%
Shareholder yield6.1%2.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: IH or LOW

Didn't find what you were looking for?

Ask us
Which is bigger, iHuman or Lowe's Companies?

By market value, Lowe's Companies ($124B) is about 3,070.7 times iHuman ($40M), at today's prices.

How did IH and LOW stock do over the last 5 years?

Since November 19, 2021, IH's price moved -84.5% and LOW's -11.5%. With dividends: IH -81.7% (-28.8% a year), LOW -2.2% (-0.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, IH or LOW?

The dividend yield at today's price is none for iHuman and 2.22% for Lowe's Companies. Over the last twelve months they paid – and $4.90 per share.

Which has the higher profit margins, iHuman or Lowe's Companies?

Over the last twelve months, the net margin was 11.8% for iHuman and 7.3% for Lowe's Companies, and the operating margin 8.3% and 11.4%. Revenue was $115M and $90.4B.

Which is the better investment, iHuman or Lowe's Companies?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.